Raymond James & Associates’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-427,462
Closed -$40.6M 3792
2018
Q3
$40.6M Sell
427,462
-16,868
-4% -$1.44M 0.06% 284
2018
Q2
$34.3M Buy
444,330
+17,217
+4% +$1.29M 0.06% 312
2018
Q1
$29.5M Buy
427,113
+41,267
+11% +$3.15M 0.05% 342
2017
Q4
$28.8M Sell
385,846
-21,257
-5% -$1.36M 0.05% 342
2017
Q3
$25.8M Buy
407,103
+26,470
+7% +$1.65M 0.05% 358
2017
Q2
$24.3M Buy
380,633
+29,617
+8% +$1.86M 0.05% 348
2017
Q1
$23.1M Sell
351,016
-135,168
-28% -$9.3M 0.05% 343
2016
Q4
$33.4M Sell
486,184
-113,675
-19% -$8.15M 0.09% 229
2016
Q3
$42.3M Buy
599,859
+22,118
+4% +$1.65M 0.12% 186
2016
Q2
$43.8M Buy
577,741
+23,053
+4% +$1.69M 0.14% 163
2016
Q1
$38.1M Sell
554,688
-100,578
-15% -$7.23M 0.13% 165
2015
Q4
$57.3M Buy
655,266
+30,883
+5% +$2.65M 0.21% 105
2015
Q3
$50.5M Buy
624,383
+11,936
+2% +$1.04M 0.21% 100
2015
Q2
$54.5M Buy
612,447
+102,776
+20% +$8.98M 0.21% 99
2015
Q1
$44.2M Buy
509,671
+21,350
+4% +$1.79M 0.19% 103
2014
Q4
$41.3M Buy
488,321
+63,623
+15% +$4.97M 0.2% 99
2014
Q3
$30M Buy
424,698
+696
+0.2% +$49.6K 0.17% 107
2014
Q2
$29.4M Buy
424,002
+52,300
+14% +$3.68M 0.18% 101
2014
Q1
$27.9M Buy
371,702
+52,844
+17% +$3.96M 0.19% 94
2013
Q4
$22.4M Buy
318,858
+50,903
+19% +$3.32M 0.17% 118
2013
Q3
$16.6M Buy
267,955
+20,594
+8% +$1.33M 0.14% 143
2013
Q2
$15.3M Buy
+247,361
New +$14.9M 0.14% 142

Other funds holding ESRX

Raymond James & Associates's ESRX Position: Q4 2018 in Review

Raymond James & Associates sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 427,462 shares — an estimated $40.6M sold.

Raymond James & Associates first reported a position in ESRX in Q2 2013 and held it in 22 quarters. The position peaked at $57.3M in Q4 2015. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Raymond James & Associates reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Raymond James & Associates sold 427,462 Express Scripts Holding Company shares in Q4 2018, an estimated $40.6M.
  • Raymond James & Associates first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 22 quarters.
  • Raymond James & Associates's Express Scripts Holding Company position peaked at $57.3M in Q4 2015.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.